Bioequivalency Study of CM082 Tablet in Healthy Volunteers

NCT04328506 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumors

Interventions

DRUG: CM082 tablet (test product)
DRUG: CM082 tablet (reference product)

Sponsor

AnewPharma